Association of elevated D-dimer with disease severity, length of stay and in-hospital mortality among patients admitted for acute exacerbation of chronic obstructive pulmonary disease: A real-world cohort study from a tertiary centre in Karachi, Pakistan (2023-2024)

Authors

  • Rabia Seher Alvi Jinnah Postgraduate Medical Center, Karachi Pakistan/ Chiniot General Hospital, Karachi Pakistan
  • Khola Iftikhar Jinnah Postgraduate Medical Center, Karachi Pakistan/ Liaquat National Hospital, Karachi Pakistan
  • Nausheen Saifullah Jinnah Postgraduate Medical Center, Karachi Pakistan
  • Huma Umer Sama Jinnah Postgraduate Medical Center, Karachi Pakistan
  • Wardha Khan Jinnah Postgraduate Medical Center, Karachi Pakistan
  • Afsheen Saba Hadis Jinnah Postgraduate Medical Center, Karachi Pakistan/ Sohail Trust Hospital, Karachi Pakistan

DOI:

https://doi.org/10.55629/pakjpathol.v36i2.918

Abstract

Objective: To quantify the prevalence of elevated D-dimer levels, explain their link with clinical severity, hospital length of stay (LOS), and all-cause in-patient mortality, and compare our findings to current international research.

Material and Methods: A total of 146 patients diagnosed with AECOPD to Jinnah Postgraduate Medical Centre (JPMC) between February 10 and August 9, 2023 were included. AECOPD severity was categorized as moderate or severe. The major exposure was an admission D-dimer of > 0.985 mg/L. The outcomes included illness severity, LOS, and in-hospital death. Frequencies were compared using χ²/Fisher's exact tests, and LOS using independent t-test.

Results: The results showed that D-dimer was increased in 125 (85.6%). Among patients with elevated D-dimer levels, 103 (82.4%) had moderate AECOPD and 22 (17.6%) had severe AECOPD. However, among those with normal D-dimer levels, 20 (95.2%) had moderate AECOPD and only 01 (4.8%) had severe AECOPD. Although there was higher proportion of severe cases in the elevated D-dimer group, while there was not statistically significant association found between AECOPD Severity   and D-dimer levels as p value= 0.199.

Conclusions: Although almost 90% of Pakistani AECOPD patients had D-dimer levels above the diagnostic threshold, in this real-world cohort, the marker provided no independent distinction for bedside risk stratification. Large multicenter trials using venous thromboembolic imaging and longitudinal follow-up are needed.

Keywords: D-dimer, Mortality, AECOPD, COPD

References

Global Initiative for Chronic Obstructive Lung Disease. 2024 GOLD Report. Fontana: GOLD; 2024. Available from: https://goldcopd.org/2024-gold-report/

Mei F, Dalmartello M, Bonifazi M, Bertuccio P, Levi F, Boffetta P, Negri E, et al. Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019. Respirology. 2022;27(11): 941-50. DOI: https://doi.org/10.1111/resp.14328

Abebe EC, Dejenie TA, Anley DT, Mengstie MA, Gebeyehu NA, Adella GA, et al. Diagnostic performance of plasma D-dimer, fibrinogen, and D-dimer to fibrinogen ratio as potential biomarkers to predict hypertension-associated acute ischemic stroke. Heliyon. 2024; 10(5). 10(5):e27192. DOI: https://doi.org/10.1016/j.heliyon.2024.e27192

Saphira, Kakar K, Gulandam, Gulzar MA, Babar SDA, Afzl M, et al. Diagnostic accuracy of raised d-dimer level for assessment of severity of community acquired pneumonia. Res Med Sci Rev. 2025; 3 (5): 599-604. DOI: https://doi.org/10.5281/zenodo.15462916

Zhang Q, Liu JX, Bai JS, Wang JM, Fu AS, Liu RX, et al. D-dimer and procalcitonin improve sensitivity of BAP-65 for ICU admission in AECOPD. Clin Lab. 2023; 69(2): e240101. DOI: https://doi.org/10.7754/clin.lab.2022.220343

Aydin C, Yıldız BP, Hattatoğlu DG. D-dimer/ fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in patients with COPD exacerbation. Malawi Med J. 2021; 33(4): 276-80. DOI: https://doi.org/10.4314/mmj.v33i4.8

Khan MS, Biswas BK, Yasmin S, Paul CR, Ireen RA, Rashid HA, et al. Association of serum D-dimer Level with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). Chest Heart J. 2021; 45(2): 78-85. Available from: https://www.banglajol.info/index.php/CHJ/article/view/64856

Reid BE, DiGiuseppe S, Akbarian-Tefaghi H. Elevated D-dimer in end-stage COPD with hypercapnia. Cureus. 2025; 17(2): e79574. DOI: https://doi.org/10.7759/cureus.79574

Gómez-Rosero JA, Cáceres-Galvis C, Ascuntar J, Atencia C, Vallejo CE, Jaimes F. Biomarkers as a prognostic factor in COPD exacerbation: a cohort study. COPD. 2021; 18(3): 325-32. DOI: https://doi.org/10.1080/15412555.2021.1922370

GOLD Science Committee. Biomarkers in AECOPD: 2024 evidence review. Gold Sci Rep. 2024; 2: 45-63.

Available from: https://goldcopd.org/wp-content/uploads/2024/02/GOLD-2024_v1.2-11Jan24_WMV.pdf

Husain MO, Chaudhry IB, Blakemore A, Shakoor S, Husain MA, Lane S. Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan. SAGE Open Med. 2021; 9: 20503121211032813. DOI https://doi.org/10.1177/20503121211032813

Akhter S, Priya S, Ahmed N, Rizvi N. Standards of inpatient care during Acute Exacerbation of COPD in a tertiary care hospital of Karachi, Pakistan. RMJ. 2022; 47(2): 306-10. Available from: https://www.rmj.org.pk/fulltext/27-1610730025.pdf? 1750397773

Fu X, Zhong Y, Xu W, Ju J, Yu M, Ge M, et al. The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. PLoS One. 2021; 16(9): e0256480. DOI: https://doi.org/10.1371/journal.pone.0256480

Husebø GR, Gabazza EC, D'Alessandro Gabazza C, Yasuma T, Toda M, Aanerud M, et al. Coagulation markers as predictors for clinical events in COPD. Respirology. 2021; 26(4): 342-51. DOI: https://doi.org/10.1111/resp.13971

Husebø GR, Gabazza EC, D'Alessandro Gabazza C, Yasuma T, Toda M, Aanerud M, et al. Coagulation markers as predictors for clinical events in COPD. Respirology. 2021 Apr;26(4):342-51.

Macchia A, Monte S, Romero M, D'Ettorre A, Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail. 2007; 9(9): 942-8. DOI: https://doi.org/10.1016/j.ejheart.2007.06.004

Husebø GR, Gabazza EC, D'Alessandro Gabazza C, Yasuma T, Toda M, Aanerud M, et al. Coagulation markers as predictors for clinical events in COPD. Respirology. 2021 Apr;26(4):342-51.

Han C, Zhao Y, Cheng W, Yang J, Yuan J, Zheng Y, et al. The performance of age-adjusted D-dimer cut-off in Chinese outpatients with suspected venous thromboembolism. Thromb Res. 2015; 136(4): 739-43. DOI: https://doi.org/10.1016/j.thromres.2015.07.024

Priya RA, Mohapatra MM, Saka VK, Kar R, Chakkalakkoombil SV, Vemuri MB. Haematological and inflammatory biomarkers among stable COPD and acute exacerbations of COPD Patients. Sultan Qaboos Univ Med J. 2023: 239-44. DOI: https://doi.org/10.18295/squmj.12.2022.062

Li L, Feng O, Yang C. The D-Dimer to albumin ratio could predict hospital readmission within one year in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chronic Obstructive Pulmon Dis. 2024; 19: 2587-97. DOI: https://doi.org/10.2147/COPD.S481483

Lu CT, Fang TP, Hung MS, Lin YT. Clinical outcomes in ventilator-associated pneumonia patients with and without chronic obstructive pulmonary disease: A retrospective observational study. J Chin Med Assoc. 2024; 88 (1): 65-70.

DOI:https://doi.org/10.1097/jcma.0000000000001176

Downloads

Published

30-06-2025

How to Cite

1.
Alvi RS, Iftikhar K, Saifullah N, Sama HU, Khan W, Hadis AS. Association of elevated D-dimer with disease severity, length of stay and in-hospital mortality among patients admitted for acute exacerbation of chronic obstructive pulmonary disease: A real-world cohort study from a tertiary centre in Karachi, Pakistan (2023-2024). Pak J Pathol [Internet]. 2025 Jun. 30 [cited 2026 Nov. 18];36(2):157-62. Available from: https://www.pakjpath.com/index.php/Pak-J-Pathol/article/view/918